Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use.

Saved in:
Bibliographic Details
Title: Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use.
Authors: Ramaekers JG; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands. j.ramaekers@maastrichtuniversity.nl., Kuypers KPC; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., Vollenweider FX; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Source: Molecular psychiatry [Mol Psychiatry] 2026 Aug; Vol. 31 (8), pp. 4799-4810. Date of Electronic Publication: 2026 Apr 08.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5578 (Electronic) Linking ISSN: 13594184 NLM ISO Abbreviation: Mol Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5578
DOI:10.1038/s41380-026-03602-7